Joby Aviation Files Prospectus for Resale of 2.42M Shares from Strata Acquisition

What Happened
Joby Aviation, Inc. filed a prospectus supplement on September 10, 2026 (pursuant to Rule 424(b)) to register the resale of 2,419,801 shares of its common stock that were issued to a selling stockholder after certain EBITDA milestones were achieved by the acquired operations. These shares relate to Joby’s acquisition of the passenger segment and operations of Strata Critical Medical, Inc. (f/k/a Blade Air Mobility, Inc.), Trinity Medical Intermediate II, Inc., and Blade Urban Air Mobility, Inc. The prospectus supplement is part of Joby’s Form S-3 Registration Statement (No. 333-282809). A legal opinion from Latham & Watkins LLP regarding the validity of the issuance is filed as Exhibit 5.1.

Key Details

• 2,419,801 shares of common stock are covered by the prospectus supplement.
• Prospectus supplement filed with the SEC on September 10, 2026 (Rule 424(b)).
• Shares were issued upon achievement of EBITDA milestones by the acquired operations during the 12‑month period following closing of the acquisition.
• Legal opinion of Latham & Watkins LLP filed as Exhibit 5.1 and incorporated by reference into the Form S-3 (originally filed October 24, 2024).

Why It Matters
This filing registers shares that can now be resold by the selling stockholder, which increases the pool of shares that could enter the market. That additional supply may affect liquidity and share availability; it does not itself report earnings, revenue, or other operating results, but it does indicate that earn‑out/EBITDA targets tied to the Strata (Blade) acquisition were met. Investors should view this as a capital‑markets disclosure about share issuance and resale mechanics rather than a standalone financial performance filing.